What this is
- The research develops a tRNA:guide RNA (gRNA) platform for gene editing in Candida tropicalis, enhancing efficiency in gene manipulation.
- This platform utilizes the organism's own tRNA-processing system to produce mature gRNAs, improving gene editing and silencing.
- The study also establishes a CRISPR interference () system for regulating gene expression, targeting both exogenous and endogenous genes.
Essence
- The significantly improves gene editing efficiency in Candida tropicalis, enabling precise regulation of gene expression through a newly developed system.
Key takeaways
- The allows for efficient multi-gene editing, achieving a knockout efficiency of 71.0 ± 4.8% in transformed colonies.
- The system effectively downregulated the expression of targeted genes, with transcription levels reduced to 23.9% ± 4.1% for the exogenous gene and 38.0% ± 7.4% for the endogenous gene.
- This system was applied to enhance β-carotene biosynthesis in a modified C. tropicalis strain, demonstrating its potential for metabolic engineering.
Caveats
- The efficiency of the system may vary based on the specific targeting regions within the genes, complicating predictions of gene regulation outcomes.
- The study primarily focuses on a single strain of C. tropicalis, which may limit the generalizability of the findings to other strains or species.
Definitions
- CRISPRi: A gene regulation technique using a catalytically inactive Cas9 protein to inhibit gene expression without altering the DNA sequence.
- tRNA:gRNA platform: A system that uses transfer RNA sequences to express and process guide RNAs for targeted gene editing.
Simplified
INTRODUCTION
Candida tropicalis is an industrial microorganism with a special ω-oxidation pathway that is applied in the transformation of n-alkanes to aliphatic long-chain α, ω-dicarboxylic acids (DCs) (1–3). In recent years, C. tropicalis has been used in the production of xylitol (4–6) and polyhydroxybutyrate (PHB) (7) and bioremediation of heavy metals in environmental protection (8). C. tropicalis has many advantages, such as robust tolerance to furfural in the pretreatment of lignocellulosic biomass (8) and the availability of inexpensive, raw, starchy agro-products in PHB production (7).
Clustered regularly interspaced short palindromic repeats (CRISPR) system is a prokaryotic immune system that operates via CRISPR-associated (Cas) proteins that can recognize specific nucleic acids with guidance of a CRISPR RNA (crRNA). Some of those Cas proteins, especially CRISPR-Cas9, are being harnessed as tools for genome editing (9). Recently, a CRISPR interference (CRISPRi) has been established as a general tool for specific regulation of gene expression in both prokaryotes (10–12) and eukaryotes (9). The CRISPRi system consists of catalytically inactive Cas9 protein (dCas9) and a chimeric guide RNA (gRNA) (11, 12). Guided by the gRNA, the dCas9 protein binds to the target DNA region via Watson-Crick base pairing (11). If the binding site is within the promoter region or the coding sequence of a gene, RNA polymerase binding or elongation will be sterically blocked to some extent, resulting in transcriptional repression of the target gene and decreased protein production.
The CRISPRi system provides a tool to manipulate host genomes without irreversibly knocking out genes. Moreover, it has been utilized for rewiring and regulating metabolic networks in microbial cell factories. This regulation system can modulate biosynthesis pathway fluxes to balance mevalonate (MVA) pathway genes in terpenoid production (13, 14). In yeast cells, CRISPR regulation systems have been developed in Saccharomyces cerevisiae (15–17), Schizosaccharomyces pombe (18), Pichia pastoris (19), and Yarrowia lipolytica (20). However, a CRISPRi system has not been constructed in C. tropicalis, hindering the regulatable manipulation of gene expression in this organism.
When applying CRISPR tools, both RNA polymerase type II (Pol II) and RNA polymerase type III (Pol III) promoters can be used to produce gRNAs. Transcription from RNA Pol III promoters is different from that from RNA Pol II promoters responsible for mRNAs. RNAs transcribed by RNA Pol III remain in the nucleus instead of being transported to the cytoplasm. Among them, U3 and U6 are early RNA Pol III promoters commonly used to produce gRNAs (21). However, the functions of many RNA Pol III promoters are not yet clear in many species, and their applications are very limited. Researchers have paid attention to the central adapter molecules, tRNAs, which are highly expressed in cells, accounting for 4 to 10% of total cellular RNAs (22). In the maturation process of tRNAs in organisms, tRNAs undergo ribozyme cleavage at specific sites. Therefore, a tRNA:gRNA platform contributes to precise and efficient gRNA processing with desired 5′ targeting sequences. Compared with other gRNA expression techniques, the advantages of the tRNA:gRNA platform are as follows. (i) The tRNA:gRNA platform enables broad-host range applications, because the tRNA-processing system exists in almost all organisms (23). It fills the gap in available RNA Pol III promoters in new hosts (24). (ii) The tiny size is more suitable in producing different gRNAs from a single polycistronic gene (25). The length of nuclear encoded eukaryotic and prokaryotic tRNAs is less than 90 nucleotides (26). Accordingly, it leaves more space for vectors with limited packaging capacity (27). (iii) It hardly causes potential cell burden. In some gRNA techniques, heterologous endonuclease Csy4 or ribozymes are needed (28), which carries additional risk of toxicity in heterologous gene expression (25). In rice plants, the tRNA:gRNA platform was first used in multiplex genome editing and chromosomal-fragment deletion. This showed that tRNAs could produce large amounts of gRNA (25). Further, the tRNA-gRNA platform was applied in a S. cerevisiae multiplexed engineering system (GTR-CRISPR). The 2-promoter GTR-CRISPR allowed simultaneous disruptions of 8 genes with 87% efficiency (29).
In the present work, we developed a gRNA expression strategy and a CRISPRi system in C. tropicalis. We first obtained an endogenous tRNA encoding gene (tRNAGly) from C. tropicalis ATCC 20336. It could serve as an available RNA Pol III promoter for expression of multiple gRNAs mediating single-gene disruption. Additionally, a tRNA:gRNA platform expressing multiple gRNAs for Cas9-mediated targeting was designed. A dCas9-based CRISPRi system was designed, which, in combination with the tRNA:gRNA platform, was applied to regulate exogenous and endogenous gene transcription. Regions downstream and upstream of the initiation codon were chosen, and suitable target sites in both regions were used to downregulate transcription of respective genes. The repression ability of the CRISPRi system in C. tropicalis was further verified in regulating β-carotene biosynthesis in C. tropicalis.
RESULTS
Analysis of endogenous tRNAs inATCC 20336. C. tropicalis
Utilizing tRNAscan-SE software (30), the whole genome of C. tropicalis was searched for tRNA-coding sequences. After excluding eight pseudogenes, we obtained 20 types of tRNAs related to transporting different amino acids in different quantities. In addition, among the various tRNAs, some were predicted to contain introns in the coding sequence (Fig. 1A). The six types of tRNAs predicted without introns were tRNAAla, tRNAGly, tRNAVal, tRNAMet, tRNAGln, and tRNAAsp. Since the tRNAGly sequences lack introns and are short in length, they are suitable as RNA Pol III promoters. Therefore, we aligned the 17 sequences of the endogenous tRNAGly in C. tropicalis ATCC 20336, together with publicly available tRNA sequences of C. tropicalis MYA 304 and C. tropicalis 121 (see Fig. S1 in the supplemental material). Interestingly, we found that some of the C. tropicalis tRNAGly sequences were highly similar. Since we aimed to develop a tRNA able to serve as a potential promoter for transcription and processing of multiple gRNAs from one array, the secondary structure was also analyzed with tRNAscan-SE (30). Comparing the C. tropicalis tRNAGly (Fig. 1B) with the previously reported tRNAGly in Y. lipolytica (31) and rice (25), even though the sequences are quite different, the nucleotides close to the ribozyme cleavage sites are the same (Fig. 1C). As the ribozyme cleavage sites of the tRNAGly sequences were confirmed in other studies, we concluded that the ribozyme cleavage sites were consistent in the coding sequences of tRNAGly.
Information on endogenous tRNAs inATCC 20336. (A) Statistical result of tRNAs in the genome ofATCC 20336. Orange refers to the total quantity. Blue refers to the number of tRNAs without introns. (B) The secondary structure of a tRNAsequence inATCC 20336. (C) Based on referencesand, a partial sequence diagram of previously reported tRNAin(blue) and the one in rice (purple). The yellow square frame highlights the consistent nucleotides. C. tropicalis C. tropicalis C. tropicalis Y. lipolytica Gly Gly [23] [26]
Functional analysis of the tRNAas an available RNA Pol III promoter. Gly
To verify the availability of the candidate tRNAGly, we fused a transient CRISPR-Cas9 cassette with the tRNA:gRNA array targeting URA3 (ptsgURA3) (Fig. 2A, Fig. 3A, and Sequence S1). The final Cas9-ptsgURA3 construct and the donor were transformed into C. tropicalis ATCC 20336. The donor was designed to carry an EcoRI restriction site and contained 50-bp homologous regions upstream and downstream of URA3. One hundred transformants on the screening plate were verified by PCR and EcoRI digestion. For this, the genomic DNA of the colonies was isolated and used as the template in PCR using the primers URA3-F and URA3-R (Table S2). The results of EcoRI digestion and sequencing showed that URA3 was successfully edited in all colonies in three independent experiments.
The tRNA:gRNA platform with the tRNAsequence. N20 refers to 20-nt targeting sequence in gRNAs. (A) gRNA for single gene target. (B) gRNA for double-gene targets. Gly
Single-gene and multi-gene knockout with a reconstructive CRISPR-Cas9 system. (A) The transientfragment used in two copies ofknockout., codon optimizedgene from; N20 refers to 20-nt targeting sequence in. FOA-SM plate, SM supplemented with 2 g/L (wt/vol) 5-fluoroorotic acid. (B) Multi-gene knockout with the aid of the tRNA:gRNA platform. Cas9-ptsgURA3 URA3 SpCas9 Cas9 Streptococcus pyogenes URA3
Multi-gene disruption was achieved with high efficiency using the tRNA:gRNA platform.
After demonstrating adequate efficiency for single-gene editing, the tRNA:gRNA platform was tested for multi-gene editing. We constructed the tRNA:gRNA platform targeting GFP3 and URA3, paying particular attention to the junction of the gRNAs (Fig. 2B, Fig. 3B). More precisely, the polyU tail in the gRNA scaffold was removed between the consecutive gRNAs, based on an effective design for tRNA-gRNA direct fusions for gene editing in Y. lipolytica (31). The transformants on the screening plate were verified by PCR using primers URA3-F, URA3-R, GFP3-F, and GFP3-R listed in Table S2. EcoRI digestion, HindIII digestion, and DNA sequencing analysis were performed for assessing multi-gene editing efficiency (Fig. S2). At first, transformation of the two donors and the tRNA:gRNA platform reached only a 5% knockout efficiency for both genes. The donors were then fused to the termini of the tRNA:gRNA platform to enhance the editing rate (Fig. 2B), and 71.0 ± 4.8% of C. tropicalis GU colonies were correctly edited in the genome (Table 1).
| gRNA and donor | No. of colonies selected from FOA-SM plates | No. of correct recombinants | Homologous recombination efficiency(%) 1 |
|---|---|---|---|
| Transient 1 | 100, 110, 120 | 5, 5, 5 | 4.6 ± 0.4 |
| Transient DNA fragment 1 | 105, 108, 120 | 69, 78, 90 | 71.0 ± 4.8 |
The CRISPRi system effectively represses the exogenous gene. GFP3
To implement the CRISPRi system in C. tropicalis, a synthetic Cas9 gene, based on the Cas9 gene from Streptococcus pyogenes, was inactivated by amino acid point mutations (dSpCas9, N10A, and H840A) (11). The 3′ terminus of dSpCas9 was appended with a triple repeat of the SV40 nuclear localization signal, and the expression cassette consisted of the strong constitutive GAP1 promoter and the ENO1 terminator (32). The expression cassette was transformed into C. tropicalis Cu-206 to generate C. tropicalis D1. Since it was verified that the GAP1 promoter supported high expression of genes in our previous work (32), we further transformed the reporter GFP3 cassette with a GAP1 promoter in the present work. The resulting strain was named C. tropicalisGFP3 interference 0 (Gi0), and dSpCas9 expression hardly affected the growth of C. tropicalis (Fig. S3).
Since the expression of both dSpCas9 and GFP3 depend on the strong constitutive GAP1 promoter, the designed targeting region should be within the coding sequence (CDS) instead of the promoter sequence of GFP3 to avoid disturbing the expression of dSpCas9. Four different regions in the CDS of GFP3 were selected, based on which complementary gRNAs were generated (Fig. 4A): GiA (+6), GiB (+48), GiC (+96), and GiD (+249). The first nucleotide of 5′-N20 targeting sequences in GFP3 (Table. S1) was marked to show the distance from the translation initiation codon (ATG) (Fig. 4A). After integrating the GFP3 interference (Gi) cassette into the POX5 locus in the genome, the green fluorescence intensity of the control (C. tropicalis Gi0) was stronger than that of the others, as observed by fluorescence microscopy (Fig. 5).
To gain an insight into the exact fluorescence of the mutants, the mean fluorescence intensity (MFI) of the single yeast cell was determined by flow-cytometry analysis. The relative MFI values of C. tropicalis GiA, C. tropicalis GiB, C. tropicalis GiC, and C. tropicalis GiD were 34.3 ± 0.5%, 39.1 ± 1.0%, 37.0 ± 0.1%, and 38.1 ± 0.4%, respectively. The relative expression levels of GFP3 were measured further (Fig. 4B). The GFP3 expression level in C. tropicalis GiA was repressed to 23.9% ± 4.1%, and in the other strains, the values were similar (Fig. 4C). Thus, it was confirmed that the CRISPRi system in C. tropicalis could repress the expression of exogenous genes. Selection of the CDS region proved reliable for achieving relatively high suppression.
Regulation ofexpression by targeting the CDS region. (A) Different regions for gRNA design for targeting. (B) Relative mean fluorescence intensity (MFI) of the yeasts integrated with different cassettes to regulateexpression. (C) Relative transcription levels ofin the yeasts. Data are represented as mean ± standard deviation from at least three biological replicates. GFP3 GFP3 GFP3 GFP3
Fluorescence observation of. The cells under the brightfield (left) and the excitation light (right). The parameters of the imaging were kept consistent.Gi0 was the control. C. tropicalis C. tropicalis
Interference effects differ among different gRNAs.
We investigated whether the targeting sites upstream and downstream of the translation initiation codon (ATG) were both available for regulating the target genes. ADE2, an important gene in the adenine biosynthesis pathway, was selected as the endogenous reporter gene. The promoter and the coding region of the endogenous genes in diploid yeast differed to various extents. We first knocked out one copy of ADE2 in C. tropicalis D1, and the other copy was maintained, generating the C. tropicalis strain Da. Eight different regions in ADE2 were chosen to design gRNAs (Fig. 6A): AiA (+164), AiB (−119), AiC (−212), AiD (+286), AiE (−19), AiF (−150), AiG (−195), and AiH (−345). The detailed targeting sequences are listed in Table S1. Quantitative real-time PCR (qRT-PCR) was used for the measurement of downregulation of ADE2 (Fig. 6B). The regions AiC and AiG achieved obvious downregulation, with relative expression levels of 39.5 ± 1.5% and 38.0 ± 7.4%, respectively. However, in C. tropicalis AiF, there was no obvious downregulation of ADE2. For the other targeted regions, the relative expression levels ranged from 62.8 ± 3.0% (AiH) to 82.7 ± 3.1% (AiD). Thus, the promoter region in C. tropicalis is suitable for flexible regulation in the CRISPRi system.
To further analyze whether adenine biosynthesis was affected, the cell density (optical density at 600 nm [OD600]) of C. tropicalis mutants in which ADE2 was downregulated was measured every 3 h. The growth curves of C. tropicalis mutants showed that silencing of ADE2 resulted in growth suppression (Fig. 6C). The growth rate was in accord with the ADE2 expression level, and C. tropicalis AiG grew slowest in the first 12 h among the nine strains. On the MM plate, the colony of C. tropicalis AiG appeared smaller than that of C. tropicalis Ai1 (Fig. S4).
Regulateexpression by targeting the promoter region. (A) Different regions for N20 design in. (B) Relative transcription levels ofin the yeasts. Data are represented as mean ± standard deviation from at least three independent occasions. (C) The growth curve of themutants in MM. The data represent the means ± standard deviations of biological triplicates. ADE2 ADE2 ADE2 C. tropicalis
Applying the system to metabolic regulation of β-carotene.
In a previous study, a heterologous β-carotene synthetic pathway was constructed in C. tropicalis DRPB (32). In the metabolic pathway, GGPP (geranylgeranyl diphosphate) is a common precursor of diterpenoids, and its accumulation reflects terpene production. The sterol biosynthesis pathway is the major farnesyl pyrophosphate (FPP)-consuming pathway in S. cerevisiae, and knockdown of squalene synthase-encoding gene ERG9 increased production of carotenoid (33). In C. tropicalis DRPB, we aimed to reduce the transcription level of ERG9 using the CRISPRi system, in order to explore the influence of ERG9 on β-carotene production (Fig. 7A). Based on valid targeting regions of the genes GFP3 and ADE2, we selected three targets on ERG9: EiA (+20), EiB (−41), and EiC (+130). The expression cassette was integrated at the CAT locus (Fig. S5). The strain C. tropicalis DRPB was chosen as the control. From the qRT-PCR results, the relative transcription levels of ERG9 were 74.1 ± 3.2%, 23.1 ± 4.7%, and 32.3% ± 1.5%, in C. tropicalis EiA, C. tropicalis EiB, and C. tropicalis EiC, respectively (Fig. 7A). Next, we analyzed the β-carotene production ability of each strain using high-performance liquid chromatography (HPLC). As shown in Fig. 7B, β-carotene reached 0.42 ± 0.02 mg/g of dry cell weight in C. tropicalis EiB. In C. tropicalis EiA and C. tropicalis EiC, β-carotene reached was 0.21 ± 0.05 and 0.26 ± 0.02 mg/g of dry cell weight, respectively. Comparing the yield of β-carotene with the relative transcription levels, we found that the strain with the lowest expression of ERG9 accumulated the highest yield of β-carotene. Results in Pearson test showed that the yield of β-carotene and the relative expression level of ERG9 were negatively related (r = −0.820, P < 0.05). The knockdown of ERG9 enhanced the accumulation of β-carotene in C. tropicalis. Additionally, this confirmed that the CRISPRi system could be used for metabolic engineering of C. tropicalis.
Regulation of β-carotene biosynthesis. (A) The critical pathway of β-carotene biosynthesis in reconstructiveand relative transcription levels ofin the yeasts. (B) Yields of β-carotene production in the regulated yeasts. Data are represented as means ± standard deviations from at least three independent occasions. Significant differences are marked with different letters (< 0.05). C. tropicalis ERG9 P
DISCUSSION
In C. tropicalis, the previous CRISPR-Cas9 system employed an RNA Pol II promoter, together with a hammerhead (HH) type ribozyme and a hepatitis D virus (HDV) ribozyme (32). When using the gRNA strategy with the RNA Pol II promoter and HH and HDV ribozymes, secondary structure can be a complication. Additionally, the HH-HDV-based gRNAs did not show high disruption efficiency in C. tropicalis ATCC 20336 compared with that in S. cerevisiae (32). To simplify the construction of gRNAs, we developed a strategy for gRNA expression mediating efficient CRISPR-Cas9-based gene editing and silencing. In the present work, the whole genome sequence of C. tropicalis ATCC 20336 was investigated using bioinformatics methods (30) to identify the coding sequences of various tRNAs. tRNAs with pseudogenes were eliminated since the maturation process of these tRNAs is not clear. Research on the diversity of tRNA genes in eukaryotes shows that tRNA genes in 11 eukaryotes with the same anticodon differ elsewhere in the tRNA structure (34). Indeed, we found high similarity between genes encoding tRNAGly in C. tropicalis and those in rice and Y. lipolytica (25, 31). Next, we preliminarily selected a tRNAGly as a candidate for the gRNA expression promoter based on the reported tRNAs in rice (25) and S. cerevisiae (29). The internal elements (box A and B) of tRNAs encoding DNA sequences are believed to support transcription (35), but the promoter-tRNA-gRNA fusion cassette is highly efficient for processing gRNAs (24). Because of this, the endogenous tRNAGly and the 300-bp sequence upstream of the tRNAGly were used as the RNA Pol III promoter for constructing a tRNA:gRNA platform in this work. tRNAs have the advantage of short sequences (27), and the tRNAGly used in this work was only 71 bp. This tiny element is more efficient for rapidly constructing different gRNAs using a simple PCR procedure. Additionally, the tRNA:gRNA platform showed the potential in efficient multi-gene editing in C. tropicalis.
For the created CRISPRi system in this work, GFP3 and ADE2 were selected as reporter genes. In the present work, almost identical silencing levels were obtained when targeting within the coding region of GFP3, while the silencing levels of ADE2 fluctuated dependent on the gRNA targeting site within the promoter region. It might be difficult to predict the exact regulation level of targeted genes, as many researchers have different opinions toward the target region for effective gene knockdown, especially in yeasts (15, 36). In S. cerevisiae, 101 gRNA structures on 14 different yeast promoters were tested and a larger number of gRNA-promoter combinations failed in gene knockdown, while some gRNAs enabled nearly 3-fold expression perturbations (15). In the oleaginous yeast Y. lipolytica, 10 gRNAs targeting different regions of gfp gene were designed, but no clear correlation between the repression efficiency and targeting sites was found (37).
In metabolic engineering, the flux of a pathway must be tightly regulated to enhance the production of target chemicals (38). In S. cerevisiae, the production of α-santalene was improved 2.66-fold with a novel multifunctional CRISPR system (39). In the future, we will further optimize the CRISPRi system by testing different repressors, activators, and other nucleases (e.g., Cas12a) (28). Moreover, other tRNAs will be tested to provide more choices for designing molecular elements. We believe that the developed CRISPRi regulation system could be effectively used in metabolic engineering of C. tropicalis to establish a sophisticated cell factory.
MATERIALS AND METHODS
Plasmids, strains, and media.
Plasmids and strains used in this work are listed in Table 2. All plasmids were constructed in Escherichia coli JM109. Media for cultivating C. tropicalis cells were as follows: minimal medium (MM) contained 6.7 g/L yeast nitrogen base, 20 g/L glucose, and 10 g/L (NH4)2SO4, supplemented medium (SM) was supplemented with 0.06 g/L (wt/vol) uracil and based on MM. Fluoroorotic acid SM (FOA-SM) was supplemented with 2 g/L (wt/vol) 5-fluoroorotic acid and based on SM, yeast peptone dextrose (YPD) medium contained 20 g/L (wt/vol) glucose, 20 g/L (wt/vol) peptone, and 10 g/L (wt/vol) yeast extract, and 2× YPD medium contained 40 g/L (wt/vol) glucose, 40 g/L (wt/vol) peptone, and 20 g/L (wt/vol) yeast extract.
| Plasmids/strains | Genotype | Reference |
|---|---|---|
| Plasmids | ||
| Ts---CAT1gda324URA3 | gene disruption cassetteCAT | Zhang LH et al. () [32] |
| Ts----CAT2gda324URA3P-GFP3-TGAP1GAP1 | gene expression cassette, under control of apromoterGFP3GAP1 | Zhang LH et al. () [32] |
| PHCU06 | The transient CRISPR-Cas9 cassettes-HH-gRNA3--HDV---- P FBA1 URA3 T FBA1 P GAP1 Cas9 T ENO1 2 | Zhang LH et al. () [32] |
| Ts----P--TCAT2gda324URA3GAP1GFP3GAP1 | gene expression cassette, under control of apromoterGFP3GAP1 | Zhang LH et al. () [32] |
| ptsgURA3 2 | gRNA expression cassette,-tRNA-gRNA-PtRNAGlyURA3 | This work |
| CPTU | The transient CRISPR-Cas9 cassettesP-Cas9-T-ptsgURA3GAP1ENO1 | This work |
| ptsgGFP3 2 | gRNA expression cassette | This work |
| ptsgGU 2 | gRNA expression cassette | This work |
| d-ptsgGU | flanked with the donor ofandptsgGUGFP3URA3 | This work |
| ptsgA/B/C/D | gRNA expression cassette targeting CDS ofgeneGFP3 | This work |
| ptsgAiA/AiB/AiC/AiD/AiE/AiF/AiG/AiH | gRNA expression cassette forADE2 | This work |
| ptsgEiA/EiB/EiC | gRNA expression cassette forERG9 | This work |
| Ts---ADE2gda324URA3 | gene disruption cassetteADE2 | This work |
| Ts-POX5-P-GFP3-T-URA3GAP1GAP1 | gene expression cassette, under control ofpromoterGFP3GAP1 | This work |
| Ts-POX5-P-GFP3-T-URA3-ptsgAGAP1GAP1 | gene regulation cassetteGFP3 | This work |
| Ts--POX5P-GFP3-T-URA3-ptsgBGAP1GAP1 | gene regulation cassetteGFP3 | This work |
| Ts-POX5-P-GFP3-T-URA3-ptsgCGAP1GAP1 | gene regulation cassetteGFP3 | This work |
| Ts-POX5-P-GFP3-T-URA3-ptsgDGAP1GAP1 | gene regulation cassetteGFP3 | This work |
| Ts---POX5gda324URA3 | gene disruption cassettePOX5 | This work |
| Ts-POX5-gda324-URA3-ptsgAiA | gene regulation cassetteADE2 | This work |
| Ts-POX5-gda324-URA3-ptsgAiB | gene regulation cassetteADE2 | This work |
| Ts--POX5-gda324-URA3ptsgAiC | gene regulation cassetteADE2 | This work |
| Ts--POX5-gda324-URA3ptsgAiD | gene regulation cassetteADE2 | This work |
| Ts--POX5-gda324-URA3ptsgAiE | gene regulation cassetteADE2 | This work |
| Ts--POX5-gda324-URA3ptsgAiF | gene regulation cassetteADE2 | This work |
| Ts--POX5-gda324-URA3ptsgAiG | gene regulation cassetteADE2 | This work |
| Ts--POX5-gda324-URA3ptsgAiH | gene regulation cassetteADE2 | This work |
| Ts--------CATgda324URA3ptsgEiAPGAP1dSpCas9TENO1CAT | gene regulation cassetteERG9 | This work |
| Ts--------CATgda324URA3ptsgEiBPGAP1dSpCas9TENO1CAT | gene regulation cassetteERG9 | This work |
| Ts--------CATgda324URA3ptsgEiCPGAP1dSpCas9TENO1CAT | gene regulation cassetteERG9 | This work |
| Strains | ||
| ATCC 20336C. tropicalis | Wild type | ATCC |
| Cu-206C. tropicalis | ura3/ura3 | Zhang LH et al. () [32] |
| Cu-1C. tropicalis | ura3/ura3 CAT/cat::SpCas9 | This work |
| GUC. tropicalis | /ura3/ura3 CAT/cat::SpCas9 POX5pox5::P-GFP3-T-URA3GAP1GAP1 | This work |
| D1C. tropicalis | ura3/ura3 CAT/cat::dSpCas9 | This work |
| DaC. tropicalis | /ura3/ura3 ADE2ade2 CAT/cat::dSpCas9 | This work |
| Gi0C. tropicalis | /ura3/ura3 CAT/cat:: dSpCas9 POX5pox5::P-GFP3-T-URA3GAP1GAP1 | This work |
| GiAC. tropicalis | /ura3/ura3 CAT/cat:: dSpCas9 POX5pox5::P-GFP3-T-URA3-ptsgAGAP1GAP1 | This work |
| GiBC. tropicalis | /ura3/ura3 CAT/cat:: dSpCas9 POX5pox5::P-GFP3-T-URA3-ptsgBGAP1GAP1 | This work |
| GiCC. tropicalis | /ura3/ura3 CAT/cat:: dSpCas9 POX5pox5::P-GFP3-T-URA3-ptsgCGAP1GAP1 | This work |
| GiDC. tropicalis | /ura3/ura3 CAT/cat:: dSpCas9 POX5pox5::P-GFP3-T-URA3-ptsgDGAP1GAP1 | This work |
| Ai1C. tropicalis | /ura3/ura3 ADE2/ade2 CAT/cat:: dSpCas9 POX5pox5::gda324-URA3 | This work |
| AiAC. tropicalis | ADE2//ura3/ura3ade2 CAT/cat:: dSpCas9 POX5pox5::gda324-URA3-ptsgAiA | This work |
| AiBC. tropicalis | ADE2//ura3/ura3ade2 CAT/cat:: dSpCas9 POX5pox5::gda324-URA3-ptsgAiB | This work |
| AiCC. tropicalis | ADE2//ura3/ura3ade2 CAT/cat:: dSpCas9 POX5pox5::gda324-URA3-ptsgAiC | This work |
| AiDC. tropicalis | ADE2//ura3/ura3ade2 CAT/cat:: dSpCas9 POX5pox5::gda324-URA3-ptsgAiD | This work |
| AiEC. tropicalis | ADE2//ura3/ura3ade2 CAT/cat:: dSpCas9 POX5pox5::gda324-URA3-ptsgAiE | This work |
| AiFC. tropicalis | //ura3/ura3 ADE2ade2 CAT/cat:: dSpCas9 POX5pox5::gda324-URA3-ptsgAiF | This work |
| AiGC. tropicalis | //ura3/ura3 ADE2ade2 CAT/cat:: dSpCas9 POX5pox5::gda324-URA3-ptsgAiG | This work |
| AiHC. tropicalis | ADE2//ura3/ura3ade2 CAT/cat:: dSpCas9 POX5pox5::gda324-URA3-ptsgAiH | This work |
| DRPBC. tropicalis | ura3::carB-carRP/ura3::carB-carRP CAT/CAT | Zhang LH et al. () [32] |
| EiAC. tropicalis | /::-----ura3::carB-carRP/ura3::carB-carRP CATcatgda324URA3ptsgEiAPGAP1dSpCas9TENO1 | This work |
| EiBC. tropicalis | /::-----ura3::carB-carRP/ura3::carB-carRP CATcatgda324URA3ptsgEiBPGAP1dSpCas9TENO1 | This work |
| EiCC. tropicalis | /::-----ura3::carB-carRP/ura3::carB-carRP CATcatgda324URA3ptsgEiCPGAP1dSpCas9TENO1 | This work |
Analysis of endogenous tRNAs based on the genome sequence.
tRNAscan-SE (30) was used for searching and subsequent analysis of tRNAs in C. tropicalis ATCC 20336. Genome information was obtained from our previous study (32). The endogenous tRNAGly and the 300-bp upstream sequence were obtained as the RNA Pol III promoter for producing gRNAs and were applied in both CRISPR-Cas9 and the CRISPRi system in this work.
Construction and verification of the gRNA expression cassette.
The tRNAGly and the 300-bp sequence upstream of tRNAGly were amplified from the genome of C. tropicalis ATCC 20336. The tRNA:gRNA platform targeting URA3, ptsgURA3, was chemically synthesized (Genewiz, Suzhou, China). Other gRNA expression plasmids were derived from the plasmid ptsgURA3 by PCR.
For the single-gene disruption, the Cas9 expression cassette was obtained by digesting plasmid PHCU06 (32) with restriction enzyme SpeI. The ptsgURA3 fragment was obtained by digesting plasmid ptsgURA3 with restriction enzyme SpeI. Cas9-ptsgURA3 was constructed by ligation of the above two fragments using DNA ligation kit (TaKaRa, Dalian, China). For the multi-gene disruption, plasmid ptsgGU and the tRNA:gRNA platform were constructed from the plasmids ptsgGFP3 and ptsgURA3 using a one-step cloning kit (Vazyme, Nanjing, China). The selection of gRNAs and the construction of donors were performed according to our previous study (40). N20 sequences were selected by the bioinformatics tool sgRNACas9 (32, 40).
Verification of the tRNAGly availability was performed using the transient Cas9 expression cassette fused with the ptsgURA3 fragment. The final Cas9-ptsgURA3 construct and the donor were transformed into C. tropicalis ATCC 20336. The donors contained a stop codon and 50-bp homologous regions upstream and downstream of the cleavage sites in URA3 (orotidine monophosphate decarboxylase) and GFP3, respectively. The donor of URA3 was inserted into the EcoRI restriction enzyme, and the donor of GFP3 was inserted into the HindIII restriction enzyme site. The donor was obtained by PCR using each pair of equimolar diluted DNA primers. Primers for the donor of URA3 and GFP3 for homology-directed repair (HDR) are listed in Table S2. To explore the functions of the tRNA:gRNA platform, the fragment of the array flanked with the donors was transformed into C. tropicalis GU, which was integrated with GFP3 and URA3 at the POX5 (acyl coenzyme A oxidase I) locus. The editing rates were calculated from three independent experiments.
Construction of the CRISPRi system in. C. tropicalis
With the aid of tRNAs, we constructed the CRISPRi system by choosing C. tropicalis Cu-206 as the chassis cell and integrated dSpCas9 at the CAT locus. We further expressed GFP3 at the POX5 locus to assess the efficiency of the CRISPRi system in C. tropicalis D1. In the control stain C. tropicalis Gi0, GFP3 was expressed utilizing a GAP1 promoter, while gRNA expression cassettes fused to the terminator of GFP3 were expressed in C. tropicalis GiA, GiB, GiC, and GiD. For assessing ADE2 regulation efficiency, the construction steps for gRNA expression cassettes were similar, except that a copy of ADE2 was knocked out in C. tropicalis D1. All expression cassettes were flanked with the MluI restriction enzyme for digestion. DNA fragments were purified by the ethanol precipitation method. Yeast transformation employed the lithium chloride protocol, and the selection marker URA3 was recycled after each transformation (41). C. tropicalis is a diploid yeast, and all expression cassettes were integrated at a single locus, which was verified by PCR and DNA sequencing analysis.
Fluorescence measurement of. GFP3
Recombinant strains expressing GFP3 were cultivated until reaching an OD600 of 10 in 20 mL YPD medium and then inoculated into fresh synthetic medium with an initial OD600 of 0.05 in 50 mL YPD. Cells at a final OD600 of 2 to 3 were pelleted by centrifugation, washed twice with phosphate-buffered saline (PBS), and resuspended in PBS at an optimal density. Fluorescence images were obtained by a Nikon Eclipse 80i microscope (Nikon Corp., Tokyo, Japan) equipped with a blue laser (488 nm excitation, 530 nm emission).
Mean fluorescence intensity measurement of. GFP3
Recombinant strains expressing GFP3 were cultivated until reaching an OD600 of 10 in 20 mL YPD medium and then inoculated into fresh synthetic medium with an initial OD of 0.05 in 50 mL YPD. Cells at a final OD600 of 2 to 3 were pelleted by centrifugation, washed twice with phosphate-buffered saline (PBS), and resuspended in PBS at an optimal density. Mean fluorescence intensity (MFI) was measured by a BD FACSAria III instrument (Becton, Dickinson and Company, Shanghai, China) with a blue laser (488 nm excitation, 530 nm emission).
qRT-PCR.
C. tropicalis cells at an OD600 of 1.5 to 2.5 were collected from the YPD fermentation broth, and total RNAs were isolated using a yeast RNAiso kit (TaKaRa, Dalian, China). RNA samples were further transcribed into cDNA with a PrimeScript RT reagent kit and gDNA eraser (TaKaRa, Dalian, China) following the manufacturer’s instructions. To determine the relative expression levels via quantitative PCR (qPCR), the housekeeping gene ACT1 (accession no. FM864204.1↗) was used as a control. All qPCR experiments were carried out with a SYBR premix Ex Taq kit (TaKaRa, Dalian, China) and a CFX96 real-time PCR system (Bio-Rad, CA, USA). Primers for ACT1, GFP3, and ADE2 were CTTACGAATTGCCAGATG (qACT1-F), CTTACGAATTGCCAGATG (qACT1-R), GACACAACATTGAAGATGGT (qGFP3-F), GCAGATTGAGTGGATAAGTAAT (qGFP3-R), CCAGAATCTTGAAGCAGTT (qADE2-F), and CAGCACCAGCAATGATAC (qADE2-R).
Extracting β-carotene.
Recombinant strains accumulating β-carotene were cultivated to an OD600 of 15 to 20 in 15 mL YPD medium and then inoculated into fresh synthetic medium to an initial OD of 0.1 in 15 mL YPD. After being cultivated for 96 h, two 1.5-mL samples of fermentation broth were collected by centrifugation and washed twice using double-distilled water (ddH2O). The cellular precipitate from one sample was dried for measuring dry cell weight. The second sample was mixed with 1 mL 3 M HCl and boiled for 3 min, and the cell precipitate was collected by centrifugation (8,000 rpm) and washed with ddH2O. After being mixed with 1 mL acetone, cells were collected by centrifugation for 10 min (8,000 rpm). The supernatant liquid served as β-carotene extracting solution and was subjected to high-performance liquid chromatography (HPLC) analysis. Concentrations of β-carotene in culture broths were analyzed by Agilent 1260 Infinity (Agilent Technologies, Wilmington, USA) coupled with UV detection. Mobile phases A, B, and C were 35% methanol, 35% acetonitrile, and 30% ethyl acetate in water, respectively. The flow rate of the mobile phases was 1 mL/min, and the column temperature was 25°C. UV wavelength was 450 nm.
ACKNOWLEDGMENTS
This study was supported by the 111 Project (No. 111-2-06) and the Top-notch Academic Programs Project of Jiangsu Higher Education Institutions (award number: none). We report no conflict of interest.
Footnotes
Contributor Information
Xianzhong Chen, Email: xzchen@jiangnan.edu.cn.
Wei Shen, Email: shenwei@jiangnan.edu.cn.
Jian Li, Hubei University of Medicine.